Corvus Pharmaceuticals, Inc.CRVSNASDAQ
LOADING
|||
Switch Symbol:
EBITDA Over Time
Trending lower, above historical average.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-27.46M
↑ 20% above average
Average (9y)
$-34.24M
Historical baseline
Range
High:$-5.36M
Low:$-54.82M
CAGR
-1.4%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $-27.46M | -18.1% |
| 2023 | $-23.26M | +27.8% |
| 2022 | $-32.20M | +15.6% |
| 2021 | $-38.17M | -611.7% |
| 2020 | $-5.36M | +88.9% |
| 2019 | $-48.11M | -4.4% |
| 2018 | $-46.09M | +15.9% |
| 2017 | $-54.82M | -53.2% |
| 2016 | $-35.78M | -14.7% |
| 2015 | $-31.19M | - |